These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31043179)

  • 1. Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease.
    Metaxas A; Anzalone M; Vaitheeswaran R; Petersen S; Landau AM; Finsen B
    Alzheimers Res Ther; 2019 May; 11(1):38. PubMed ID: 31043179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice.
    Metaxas A; Vaitheeswaran R; Jensen KT; Thygesen C; Ilkjaer L; Darvesh S; Finsen B
    Curr Alzheimer Res; 2018 Mar; 15(5):420-428. PubMed ID: 28982335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.
    von Linstow CU; Waider J; Grebing M; Metaxas A; Lesch KP; Finsen B
    Alzheimers Res Ther; 2017 Sep; 9(1):74. PubMed ID: 28899417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
    J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice.
    Sivasaravanaparan M; Olesen LØ; Severino M; von Linstow CU; Lambertsen KL; Gramsbergen JB; Hasselstrøm J; Metaxas A; Wiborg O; Finsen B
    J Alzheimers Dis; 2022; 87(2):685-699. PubMed ID: 35342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
    von Linstow CU; Waider J; Bergh MS; Anzalone M; Madsen C; Nicolau AB; Wirenfeldt M; Lesch KP; Finsen B
    J Alzheimers Dis; 2022; 85(3):1283-1300. PubMed ID: 34924373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.
    Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L
    Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
    Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1B and other related serotonergic proteins are altered in APPswe mutation.
    Tajeddinn W; Persson T; Maioli S; Calvo-Garrido J; Parrado-Fernandez C; Yoshitake T; Kehr J; Francis P; Winblad B; Höglund K; Cedazo-Minguez A; Aarsland D
    Neurosci Lett; 2015 May; 594():137-43. PubMed ID: 25841787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
    Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
    Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.